TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 49 filers reported holding TOKAI PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $767,000 | -88.7% | 87,983 | -86.6% | 0.04% | -88.8% |
| Q3 2015 | $6,814,000 | -30.9% | 658,402 | -11.1% | 0.33% | -14.5% |
| Q2 2015 | $9,855,000 | +28.6% | 740,978 | +9.3% | 0.38% | +18.5% |
| Q1 2015 | $7,661,000 | -8.5% | 677,978 | +19.4% | 0.32% | -10.7% |
| Q4 2014 | $8,372,000 | +169.9% | 567,978 | +177.1% | 0.36% | +161.9% |
| Q3 2014 | $3,102,000 | – | 205,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Owl Capital Management, LLC | 130,000 | $1,729,000 | 1.23% |
| Novo Holdings A/S | 1,238,252 | $16,469,000 | 1.18% |
| Perceptive Advisors | 485,338 | $6,455,000 | 0.39% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 740,978 | $9,855,000 | 0.38% |
| Tourbillon Capital Partners, L.P. | 517,000 | $6,876,000 | 0.15% |
| SABBY MANAGEMENT, LLC | 128,041 | $1,703,000 | 0.06% |
| Alyeska Investment Group, L.P. | 613,134 | $8,154,000 | 0.05% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $80,000 | 0.04% |
| OPPENHEIMER & CO INC | 12,048 | $160,000 | 0.00% |
| FRANKLIN RESOURCES INC | 451,700 | $6,008,000 | 0.00% |